Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1Classical hematology 1CNS 1

Conditions

Leukemia, Myeloid, Acute 96Leukemia 90Myelodysplastic Syndromes 83Precursor Cell Lymphoblastic Leukemia-Lymphoma 71Lymphoma, Non-Hodgkin 62Lymphoma 60Multiple Myeloma 53Hodgkin Disease 48Leukemia, Lymphocytic, Chronic, B-Cell 46Myeloproliferative Disorders 41Leukemia, Myeloid, Chronic-Phase 41Leukemia, Myeloid, Accelerated Phase 37Congenital Abnormalities 37Lymphoma, Large B-Cell, Diffuse 35Neoplasms, Plasma Cell 34Lymphoma, Follicular 34Leukemia, Myelomonocytic, Chronic 34Burkitt Lymphoma 33Anemia, Refractory, with Excess of Blasts 32Lymphoma, Mantle-Cell 31Lymphoma, B-Cell, Marginal Zone 29Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Lymphoma, Large-Cell, Immunoblastic 28Blast Crisis 26Myelodysplastic-Myeloproliferative Diseases 25Recurrence 24Primary Myelofibrosis 24Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 24Hematologic Neoplasms 24Dendritic Cell Sarcoma, Interdigitating 22

Interventions

thymoglobulin 1fludarabine 1Rituximab 1Melphalan 1Levetiracetam 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Chromosome Aberrations × Busulfan × Clear all
NCT05735717 2026-04-06

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
70 enrolled
CNSClassical hematologyLymphoidOther hematologic neoplasm

Chromosome 7, monosomy, Anemia, Refractory, with Excess of Blasts, Chromosome Aberrations, Influenza, Human, Neurofibromatosis 1, Leukemia, Myeloid, Acute, beta-Thalassemia, Neoplasm, Residual, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile

Data powered by HemOnc (CC BY 4.0) Colophon âš¡